Status:
COMPLETED
Prostatic Cancer Versus Androgen Deficiency
Lead Sponsor:
Hopital Foch
Conditions:
Cancer of Prostate
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Open study to make a comparison between hypogonadism and euogonadism patients regarding the severity of prostate cancer. The purpose of this study is to determine the importance of the relationship be...
Eligibility Criteria
Inclusion
- Male patients over than 18 years of age, with localized, stage I or II prostate cancer, not receiving local treatment (radiation, phototherapy, thermotherapy,…) or hormonal therapy, showing indication of radical prostatectomy.
Exclusion
- Absence of radical prostatectomy indication
- Patient received local or hormonal therapy prior to surgery
- Patients already enrolled in other clinical study incompatible with the study
- Patients on a treatment which can affect hormonal level (Prednisone, Ketoconazole, Abiraterone, Finasteride, Dutasteride)
Key Trial Info
Start Date :
June 3 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 22 2021
Estimated Enrollment :
1614 Patients enrolled
Trial Details
Trial ID
NCT02235142
Start Date
June 3 2013
End Date
December 22 2021
Last Update
January 20 2022
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Saint Augustin
Bordeaux, France, 33000
2
Hôpitaux Civils de Colmar
Colmar, France, 68000
3
Hôpital Henri Mondor
Créteil, France, 94000
4
La Pitié-Salpêtrière (AP-HP)
Paris, France, 75013